Page 10 of 12
Non-serious side effects
Non-serious side effects were reported by 102 participants (38%) in the randomised
group. The table below shows the number of participants (percent) with non-serious
side effects that were reported by 3% or more of participants.
Number of participants (percent) with non-serious side effects
reported by 3% or more of participants in randomised group
Randomised
272 participants
Nausea 26 (10%)
Diarrhoea 12 (4%)
Headache 10 (4%)
Indigestion 8 (3%)
Non-randomised group (from start of open-label phase to Week 96)
Serious side effects
Serious side effects were reported by three participants (3%) in the non-randomised
group.
The following serious side effects were reported by one participant each:
• High blood potassium levels
• Inflammation of heart muscles
• Kidney stones
• Severe inflammation in the brain and/or spinal cord caused in response to
use of antiretroviral therapy
No fatal side effects were reported by participants in the non-randomised group.